MICHELE PADEN: Open Payments
NPI 1043613128 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,302 in 58 payments from 30 companies in 2025. Trend: 2023 $2,862 · 2024 $1,853 · 2025 $1,302
Food & beverage: $1,212Education: $90
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 12 | $166 |
| PFIZER INC. | 7 | $145 |
| Aveo Pharmaceuticals, Inc. | 2 | $115 |
| ABBVIE INC. | 5 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $71 |
| Kite Pharma, Inc. | 2 | $55 |
| Exelixis Inc. | 2 | $55 |
| Celgene Corporation | 2 | $54 |
| SOBI, INC | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
Products named: FOTIVDA, INJECTAFER, EPKINLY, Enhertu, IMFINZI, IBRANCE, Yescarta, CABOMETYX.
Industry payments across AZ — which companies pay providers there.
